Natural killer (NK) cells are instrumental in innate immune responses, in particular for inducing the early production of gamma interferon (IFN-␥) without prior sensitization, necessary to control bacterial, parasitic, and viral infections. Cytokines such as interleukin 12 (IL-12) stimulate NK cells to release IFN-␥ and express natural cytotoxicity. The rapid activation of NK cells is characteristic of innate immunity and constitutes the first line of defense against invading pathogens. Signals generated during the early host response have an additional role in the nature of downstream adaptive immune responses. Production of IFN-␥ ensures activation of phagocytosis by monocytes and T helper (Th) differentiation to the Th1 phenotype, thus directing the adaptive immune response towards the appropriate effector pathway to clear the infection. In many studies it has been shown that a rapid IFN-␥ response is essential for host survival (36) .
It became apparent that NK effector functions, including cytokine release, cytotoxicity, and migration, are regulated by a balance between opposite signals delivered by major histocompatibility complex (MHC) class I-specific inhibitory and activating receptors (11, 53, 56, 67) . In human NK cells, both HLA-specific and non-HLA-specific inhibitory receptors have been identified. The killer cell immunoglobulin (Ig)-like receptors and the killer cell lectin-like receptors constitute a structurally distinct family of HLA-specific receptors. The C-lectinlike receptor CD94, which forms a heterodimer with the members of the NKG2 family, recognizes HLA-E and allows monitoring of MHC class I expression on tissues (34, 43) . CD94 was also shown to be implicated in the costimulation of human NK cells (31, 64) . Inhibitory receptors prevent killing of normal cells and limit the production of NK-mediated proinflammatory cytokines, such as IFN-␥, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor (TNF) (43) .
Little is known about activating receptors on NK cells and their corresponding ligands (42) . The best-characterized receptor is FcR␥III (CD16), through which NK cells mediate antibody-dependent cellular cytotoxicity (24, 58) . NKG2D, which is expressed on NK cells, ␥␦ T cells, and CD8
ϩ ␣␤ T cells, binds several ligands that are structurally related to MHC class I. In association with DAP12, an intracellular adapter molecule, engagement of NKG2D triggers cytotoxicity (39, 47) . Two recently identified receptors, the human NKp44 and NKp46 molecules, were also shown to trigger NK cell-mediated cytotoxicity (4, 48, 55) . Resting NK cells constitutively express a number of cytokine receptors and can secrete immunoregulatory cytokines following stimulation with monokines. IL-12 produced by monocytes and dendritic cells early during infection sends a powerful signal to activate NK cells and seems particularly potent to induce IFN-␥ (10, 37, 62) . Other factors responsible for the activation of NK cells during infection have remained elusive but involve IFN-␣/␤, IL-15, IL-18, TNF, or chemokines (36) .
In vitro studies have shown that upon stimulation of lymphocytes with bacteria, including species of Staphylococcus, Salmonella, and Corynebacterium, primarily NK cells become activated and produced IFN-␥ (14, 49, 61) . Also, lactobacilli, which are commensal gram-positive bacteria, are described as potent inducers of monocyte-derived IL-12 (25, 26, 41) . Recently, it was shown that the stimulation of peripheral blood mononuclear cells (PBMC) with Lactobacillus johnsonii La1, an intestinal isolate with documented probiotic properties (1, 20, 52) , resulted in the activation of CD3 Ϫ CD56 ϩ NK cells to secrete IL-12 and IFN-␥. This was not observed when PBMC were stimulated with nonpathogenic Escherichia coli or lipopolysaccharide (22) . Thus, activation of human lymphocytes by whole gram-positive bacteria differs from that by gram-negative organisms or lipopolysaccharide, as CD14-independent pathways may be implicated (59) .
The aim of this study was to further characterize molecular requirements for NK cell activation by gram-positive bacteria in vitro. We provide evidence that IFN-␥ production by CD3 Ϫ
CD16
ϩ CD56 ϩ NK cells after stimulation with Staphylococcus aureus or L. johnsonii La1 was dependent on cell contactdependent costimulation by activated monocytes. Our data support the importance of accessory cell-derived signals in the process of NK cell activation by gram-positive bacteria.
MATERIALS AND METHODS
Bacteria. S. aureus (Nestlé culture collection, human fecal isolate) was grown aerobically in BHI broth at 37°C. L. johnsonii La 1 (Nestlé culture collection), of human intestinal origin, was cultivated in MRS broth at 37°C. All bacteria were harvested by centrifugation (1,500 ϫ g, 15 min) at stationary growth phase (18 h). Bacteria were washed three times with phosphate-buffered saline (1ϫ PBS, pH 7.2; Gibco BRL) and diluted to a final concentration of 10 3 to 10 7 CFU/ml in RPMI 1640 (Gibco BRL). Where indicated, bacteria were heat killed (100°C, 30 min), washed twice with PBS and twice with acetone, and dried at 37°C. Bacterial powders were diluted to final concentrations of 1 ng/ml to 10 g/ml in RPMI 1640.
Isolation of bacterial CW, PG, and LTA. Cell wall (CW) and peptidoglycan (PG) of S. aureus and L. johnsonii La1 were purified and prepared by modifications of the method described by Rosenthal and Dziarski (50) . Bacteria from a 3-liter culture were harvested at stationary growth phase (18 h) and exposed to 100°C for 30 min. After centrifugation (1,500 ϫ g, 4°C, 15 min) the cells were washed three times with cold PBS, resuspended in PBS containing glass beads (10 6 m; Sigma), and broken immediately with a cell disrupter at 4°C. Beads were removed by filtration. From the filtrate, unbroken cells were sedimented by a 10-min centrifugation at 1,500 ϫ g at 4°C. From the supernatant, CWs were sedimented by centrifugation at 6,500 ϫ g at 4°C for 30 min and washed twice with PBS. The absence of whole bacterial cells was controlled by Gram staining. An aliquot of the crude CW suspension was washed twice with deionized, sterile water and twice with acetone and dried at 37°C. PG was purified from isolated crude CWs by enzymatic treatment with RNase A (100 g/ml; Sigma), DNase I (50 g/ml; Sigma), and trypsin (200 g/ml; Sigma) for 18 h at 37°C in PBS (1ϫ, pH 7.2). Toluene was added to prevent bacterial contamination. Enzymatic CW purification was controlled at an optical density at 480 nm. To remove CW carbohydrate structures such as teichoic acid, covalently bound to PG, the enzyme-treated CWs were exposed to 5% trichloroacetic acid at 37°C for 12 h. The purified insoluble PG was sedimented by centrifugation at 6,500 ϫ g at 4°C for 30 min, washed twice with PBS, twice with deionized, sterile water, and twice with acetone, and dried at 37°C. Lipoteichoic acid (LTA) from L. johnsonii La1 was isolated as previously described (18) . LTA from S. aureus was purchased from Sigma. For experimental use, powders of bacterial CW, PG, and LTA were diluted in RPMI 1640 to final concentrations of 1 ng/ml to 10 g/ml.
Isolation of human CD3 ؊ CD16 ؉ CD56 ؉ peripheral blood NK cells and CD14 ؉ monocytes. Human PBMC were purified from buffy coats (Blood Transfusion Centre, Lausanne, Switzerland) by Ficoll-Hypaque (1077; Pharmacia) gradient centrifugation. PBMC were harvested from the interface, washed five times with RPMI 1640, and incubated in RPMI-10% human AB serum (Sigma) for 2 h at 37°C and 5% CO 2 on 225-cm 2 tissue culture plates (Costar) to allow adherence. Nonadherent peripheral blood lymphocytes were separated from adherent cells by aspiration. Where indicated, adherent cells were gently washed three times with prewarmed culture medium and harvested by using a rubber policeman (Costar). CD14 ϩ monocytes were purified from peripheral blood by a magnetic cell sorting positive-selection technique (Miltenyi Biotec). CD3 Ϫ
CD16
ϩ CD56 ϩ NK cells were enriched from peripheral blood lymphocytes from the same donor by depletion of T cells, B cells, and myeloid cells using indirect labeling with hapten-conjugated CD3, CD14, CD19, CD36, and anti-IgE monoclonal antibodies (MAb) and magnetic cell sorting Microbeads coupled to an antihapten MAb (NK cell isolation kit; Miltenyi Biotec). Purity was controlled by fluorescence-activated cell sorting analysis using fluorescein isothiocyanate (FITC)-and phycoerythrin (PE)-labeled anti-CD4/CD8 MAb, FITC-labeled anti-CD16, FITC-labeled anti-CD19 MAb, FITC-labeled anti-CD56 MAb, FITClabeled anti-CD14 MAb, and PE-labeled anti-CD3 MAb (all from Becton Dickinson). The purity of the isolated human peripheral blood CD3 Ϫ CD16 ϩ CD56 ϩ NK and CD14 ϩ monocytes ranged between 92 and 95%. Cell viability was controlled by trypan blue exclusion and was generally Ͼ90%. Purified NK cells were diluted in RPMI 1640 containing 10% native human AB serum, gentamicin (100 g/ml; Gibco BRL), and polymyxin B (100 g/ml; Gibco BRL) to a final concentration of 2 ϫ 10 6 /ml.
Phagocytosis of BCECF-AM-labeled bacteria by CD14
؉ monocytes. Stationary-phase bacteria were washed three times with PBS, diluted to 10 8 CFU/ml in PBS, and incubated with 10 l of 2Ј,7Ј-bis(2-carboxyethyl)-5(6)-carboxyfluorescein-acetoxy-methyl ester (1 mg/ml, BCECF-AM; Sigma) for 30 min at 37°C. The potential of CD14 ϩ monocytes to phagocytose BCECF-AM-labeled bacteria was studied by using Phagotest (Orpegen Pharma). Briefly, 20 l of BCECF-AMlabeled bacteria (10 8 to 10 5 CFU/ml) were incubated with monocytes (4 ϫ 10 5 cells/100 l) in RPMI 1640 supplemented with 10% native human AB serum and gentamicin (100 g/ml) for 20 min at 37°C. Control monocytes were incubated at 4°C. To distinguish between adherent and phagocytosed bacteria, 100 l of quenching solution (Orpegen Pharma) was added to the each sample. Finally, monocytes were washed twice with cell wash (Becton Dickinson), incubated with DNA staining solution (Orpegen Pharma) for 10 min at 4°C, and analyzed by flow cytometry (FACScan; Becton Dickinson). Bacterial uptake was confirmed by confocal microscopy (Zeiss).
Stimulation of CD3
ϩ NK cells were seeded at 2 ϫ 10 6 /ml (500 l) into 24-well tissue culture plates. Where indicated, a total of 2.5 ϫ 10 5 monocytes (50 l) were added to each well. For the stimulation of NK cells, live bacteria (10 3 to 10 7 CFU/ml), heat-killed bacteria, bacterial CW, purified PG, LTA (1 ng/ml to 10 g/ml), or recombinant human IL-12 (rhIL-12; R&D Systems) were added (500 l). The final ratio between NK cells and bacteria (live/heat killed) or bacterial components (CW, PG, and LTA) was 1:10, 1:1, 10:1, 100:1, or 1,000:1. Where indicated, NK cells were separated from monocytes and bacteria by cell culture inserts (0.4-m pore size; Nunc). In the presence or absence of monocytes, NK cells were incubated with bacteria or bacterial components for 6, 18, 28, 48, and 72 h at 37°C and 5% CO 2 . Culture medium alone was used as a control. NK cell viability (Ͼ90%) was controlled by trypan blue exclusion. Subsequently, the cells were collected, washed twice with PBS, and used for flow cytometry analysis. Cell culture supernatants were collected separately and kept at Ϫ20°C for cytokine analysis by enzyme-linked immunosorbent assay (ELISA).
Antibodies. NK cell activation was determined in the presence of anti-CD80 (36790D, IgG1 clone L307.4)/CD86 (33430D, IgG2b clone IT2.2) MAb, anti-CD14 MAb, and anti-IL-12 MAb (554659, IgG1 clone C8.6). Mouse anti-IgG1 (33811A, clone MOPC-21) and -IgG2b (33801A, clone 27-35) MAb were used as isotype control antibodies. All antibody preparations were azide free and diluted to a final concentration of 50 g/ml (Pharmingen).
Prestimulation of CD14 ؉ monocytes with bacteria or proinflammatory cytokines. Purified CD14 ϩ monocytes (10 6 /ml) were stimulated with live bacteria (10 6 CFU/ml), a mixture of TNF-␣ (5 g/ml) and IFN-␥ (50 U/ml), or medium alone. After 12 h of incubation, monocytes were washed three times with PBS and finally transferred to NK cell cultures (NK cell/monocyte ratio, 4:1). Viability of prestimulated monocytes was Ͼ90%, as assessed by trypan blue exclusion. ELISA. The concentrations of IFN-␥, IL-12 p70, IL-15, IL-10, TNF-␣, and IL-1␤ in cell culture supernatants were determined by ELISA (Eli-pair; Diaclone).
Statistics. Values are given as the means of duplicates or triplicates Ϯ standard deviations. Results were confirmed for at least three different blood donors in independent experiments. Significance was tested by applying the MannWhitney U test. stimulated monocytes alone (Fig. 3) . Of importance, IL-12 concentrations remained relatively low in all experiments (ϳ100 to 300 pg/ml). These results suggest that interactions between NK and accessory cells are mandatory for NK cell activation by gram-positive bacteria. CD69 expression in unstimulated NK cells and NK cell-monocyte cocultures remained at low levels.
RESULTS

Activation of human CD3
Whole gram-positive bacteria are necessary to induce IFN-␥ secretion by activated NK cells. To investigate whether NK cell activation is mediated by heat-stable bacterial components of gram-positive bacteria, CW, PG, and LTA were isolated from heat-killed S. aureus (Fig. 4) and L. johnsonii La1 (Fig. 5) and used for stimulation of NK cell-monocyte cocultures. Notably, administration of either purified CW, PG, or LTA from both bacteria completely failed to activate NK cells, as determined by the expression of CD69 and IFN-␥ secretion. These results suggest that disintegration of the bacterial CW significantly reduced the potential of gram-positive bacteria to activate NK cells.
Bacteria but not cytokine-activated monocytes induce NK cell activation. It appeared that monocytes play a critical role in the process of NK cell activation by gram-positive bacteria. To investigate whether NK cells specifically require bacteriumactivated monocytes, peripheral blood CD14 ϩ monocytes were preincubated with S. aureus or L. johnsonii La1 (10 6 CFU/ml), a mixture of TNF and IFN-␥, or medium alone for 16 h. Monocyte activation was controlled by IL-1␤ secretion in the supernatant (data not shown). Preactivated and unstimulated monocytes were washed prior to transfer to NK cells in order to remove nonphagocytosed/nonattached bacteria. As demonstrated in Fig. 6 (S. aureus) and Fig. 7 (L. johnsonii) , gram-
FIG. 6. S. aureus but not cytokine-activated monocytes induces NK cell activation. CD14
ϩ monocytes (10 6 /ml) were preincubated for 16 h with 10 6 live CFU of S. aureus per ml, a mixture of TNF (5 g/ml) and IFN-␥ (50 U/ml), or medium alone. Monocyte activation was controlled by measuring IL-1␤ in the supernatants. NK cells were then incubated for 72 h with pretreated monocytes as follows: (i) monocytes and bacteria, (ii) bacterium-activated monocytes, (iii) bacterium-activated monocytes and bacteria, (iv) cytokine-activated monocytes, and (v) cytokine-activated monocytes and bacteria. Unstimulated NK cellmonocyte cultures were used as a control. The expression of CD69 and the secretion of IFN-␥ were determined in triplicate. Results are representative of two experiments. ‫,ء‬ P Ͻ 0.05.
FIG. 7. L. johnsonii but not cytokine-activated monocytes induces NK cell activation. CD14
ϩ monocytes (10 6 /ml) were preincubated for 16 h with 10 6 CFU of live L. johnsonii per ml, a mixture of TNF (5 g/ml) and IFN-␥ (50 U/ml), or medium alone. Monocyte activation was controlled by measuring IL-1␤ in the supernatants. NK cells were then incubated for 72 h with pretreated monocytes as follows: (i) monocytes and bacteria, (ii) bacterium-activated monocytes, (iii) bacterium-activated monocytes and bacteria, (iv) cytokine-activated monocytes, and (v) cytokine-activated monocytes and bacteria. Unstimulated NK cell-monocyte cultures were used as a control. The expression of CD69 and the secretion of IFN-␥ were determined in triplicate. Results are representative of two experiments. ‫,ء‬ P Ͻ 0.05.
VOL. 9, 2002
NK CELL ACTIVATION BY GRAM-POSITIVE BACTERIA 653
positive bacteria but not cytokine-primed monocytes had a residual capacity to induce CD69 expression and IFN-␥ secretion by NK cells. However, NK cell activation in the presence of TNF-IFN-␥-primed monocytes was strongly reinforced after addition of live S. aureus or L. johnsonii. Analysis of phagocytosis of BCECF-AM-labeled bacteria revealed that S. aureus was 10 times more efficiently phagocytosed than L. johnsonii La1 (Fig. 8) . However, IL-1␤ secretion by activated monocytes was similar for both strains. Role of IL-12, costimulatory molecules, and CD14 in NK cell activation by whole gram-positive bacteria. When NK cellmonocyte cocultures were stimulated with S. aureus (Fig. 9a) and L. johnsonii La1 (Fig. 9b) in the presence of anti-IL-12
MAb or anti-CD80/CD86 MAb (50 g/ml), IFN-␥ secretion was significantly reduced (P Ͻ 0.05). However, IFN-␥ production was not affected in the presence of anti-CD14 MAb (50 g/ml), indicating that activation of NK cells by gram-positive bacteria was CD14 independent. IgG1 isotype antibodies were used in the controls. To dissect the role of the costimulatory molecules CD80 and CD86, the production of IFN-␥ and IL-12 by NK cell-monocyte cultures was measured after 72 h of stimulation with L. johnsonii. The secretion of IL-12 (Fig. 10A) and IFN-␥ (Fig. 10B ) was reduced to baseline levels in the presence of anti-CD80 MAb (50 g/ml) and anti-CD86 MAb (50 g/ml), respectively. Finally, the potential of IL-12 alone to induce IFN-␥ secretion by NK cell-monocyte cultures was examined at various concentrations (0, 50, 100, 500, 1,000, and 2,500 pg/ml). As shown in Fig. 10C , the addition of rhIL-12 to NK cell-monocyte cultures for 72 h resulted in weak induction of IFN-␥ (ϳ50 to 300 pg/ml) at higher IL-12 concentrations. This suggests that IL-12 alone is not responsible for the strong IFN-␥ production in NK cell-monocyte cultures after stimulation with gram-positive bacteria. We conclude from these results that cell-dependent costimulation of NK cells with monocytes is required to initiate the production of IFN-␥ by grampositive bacteria. portant gram-positive pathogens that cause a wide range of infections, including toxic shock syndrome (13, 57) . It seems controversial that lactobacilli, which have been carefully studied regarding safety (23, 27) , and pathogenic gram-positive bacteria induce similar immune responses in human leukocytes (21, 22, 25, 26, 40) . In fact, Miettinen et al. showed that both the nonpathogenic Lactobacillus paracasei GG (formerly Lactobacillus rhamnosus) and the pathogenic Streptococcus pyogenes induce secretion of the monocyte-derived cytokines (monokines) IL-12 and IL-18 (41) and activate similar signaling pathways in human monocytes, including NF-B and STAT DNA binding activity (39) . Thus, certain CW components common to nonpathogenic and pathogenic gram-positive bacteria seem to exhibit similar stimulation activities for induction of innate immune responses. In fact, the potential of pathogenic staphylococci and streptococci to produce superantigenic exotoxins is thought to primarily cause the massive cytokine induction leading to conditions of septic shock (57) . Our data suggest that monocyte-derived soluble mediators alone could not drive activation of NK cells by gram-positive bacteria. Although TNF, IL-1␤, and IL-12 were secreted by bacterium-stimulated monocytes, NK cell activation, as assessed by CD69 and IFN-␥ expression, did not occur when cellular interactions between NK cells and monocytes were prevented. Several authors have shown that murine NK cells are activated by target cells expressing the costimulatory molecules B7.1, B7.2, and CD40 (9, 35) . We showed that blocking of B7.1, B7.2, and IL-12 by MAb was highly effective in abolishing NK cell activation, suggesting that both costimulatory signals and IL-12 are necessary to trigger IFN-␥ secretion by gram-positive bacteria. This observation is also supported by reports on the increased NK cell cytotoxicity after transfection of CD80 and CD86 into target tumor cells (65) . Cell contactdependent costimulation of NK cells does not appear to involve known receptors that can costimulate T cells, including CD28, CD27, and CD29 (29) , although a recent report suggested the possibility of a variant CD28 on human NK cells (17) . However, the relevance of this finding is still a matter of controversy. By contrast, human NK cells may use other receptors. The ability of CD28 to signal via the phosphatidylinositol 3-kinase activation pathway raises the possibility that DAP10, a recently described transmembrane adapter molecule implicated in NK cell activation, may play a role similar to that of CD28 in T cells (30, 66) .
DISCUSSION
We showed that bacteria but not cytokine-preactivated monocytes retained the capacity (although reduced) to induce IFN-␥ release from NK cells. Thus, it appears that phagocytosis of S. aureus or L. johnsonii La1 provided expression of additional coactivation signals on accessory cells that may differ from those induced by TNF and IFN-␥. However, addition of live bacteria to bacterium-primed monocytes did not modulate IFN-␥ production by cocultured NK cells. This could be based on downregulation of the monocyte-specific mannosereceptor after ligation and phagocytosis of the gram-positive bacteria (54) . In contrast, cytokine-primed monocytes completely failed to induce IFN-␥ secretion in NK cells except when live bacteria were present. In this case, the IFN-␥-inductive capacity was maximal. It was recently shown that expression of pattern recognition receptors, including the mannose receptor and Toll-like receptors on monocytes (and dendritic cells) is downregulated by Th1 cytokines such as TNF and IFN-␥ (16, 44) . However, it appears that both L. johnsonii La1 and S. aureus could still efficiently trigger phagocytosis in cytokine-pretreated monocytes, most likely involving complement receptor CR3 and/or CD11b/c. Moreover, the combination of monocyte-derived signals and direct recognition of L. johnsonii La1 by NK cells via complement receptor type III (CR3 or CD18/CD11b) (12) or carbohydrate receptors, such as asialo-GM1, could not be rigorously excluded (45, 51) .
It was further demonstrated that activation of NK cells by whole gram-positive cells was CD14 independent. These data are in general agreement with those of Cauwels et al. (8) and Cuzzola et al. (12) , who described CD14-independent responses to gram-positive bacteria, including pneumococci, streptococci, and staphylococci. It is well documented that Toll-like receptor 2 is implicated in the recognition of grampositive-bacterium-derived LTA and PGs (38, 63) . Interestingly, purified CW components and LTA did not induce NK cell activation, suggesting that integral bacterial CW structure rather than isolated molecules is relevant for activation. This is confirmed by the recent finding that LTA and PG act synergistically to modulate monocyte phenotype in human whole blood (28) . There is increasing evidence that NK cell activation is regulated by the balance between inhibitory and activating signals. In addition, contact-based costimulatory signals derived from activated monocytes, dendritic cells (19) , or NKT cells (5) seem to be necessary for early IFN-␥ secretion and thus an appropriate protective innate response in the absence of antigen (46) . This in turn may profoundly influence the nature of the adaptive immune response. Thus, further to their role in innate defenses against infections, NK cells might be relevant for the microenvironmental regulation of T-cell polarization (3, 32) . Experimental evidence that selected lactobacilli may participate in the establishment of a particular microenvironment leading to a protective immune response was provided.
